Policy / Regulatory

China’s 2023 NRDL Expands Coverage with 126 New Drugs, Aims for Savings and Accessibility

CompanyDeals

AstraZeneca Acquires Icosavax to Boost Infectious Disease Pipeline with VLP Vaccine Technology

CompanyDrug

BMS Presents Promising Golcadomide Trial Results for Non-Hodgkin Lymphomas

Policy / Regulatory

Hong Kong Aims for “First-Level Approvals” with New Drug Regulatory Institution

CompanyMedical Device

Sino Medical Sciences Secures Market Approvals in Hong Kong, China, and Malaysia for Medical Devices

CompanyDrug

J&J’s Carvykti Demonstrates Extended Time to Symptom Worsening in Multiple Myeloma Patients

CompanyDrug

Dizal Pharmaceutical Presents Positive Trial Data for Golidocitinib at ASH Annual Meeting

CompanyDrug

China Medical System Gets NMPA Green Light for Phase III Vitiligo Study with Ruxolitinib Cream

CompanyDrug

CARsgen Therapeutics Halts Clinical Studies for Three CAR-T Therapies in the US Following FDA Request

CompanyDrug

Shanghai Henlius Biotech Submits Another Application for Serplulimab in China

CompanyDrug

Clover Biopharmaceuticals Commences Phase I Trial for RSV Vaccine in Australia

CompanyDrug

HutchMed’s Elunate-Tyvyt Combination Study for Renal Cell Carcinoma Completes Enrollment